δ-Catenin As a Potential Cancer Biomarker
Overview
Authors
Affiliations
Xue M, Du W, Cao J, Jiang Y, Song D, Yu D Sci Rep. 2024; 14(1):31119.
PMID: 39730828 PMC: 11681013. DOI: 10.1038/s41598-024-82391-x.
Yue Y, Tao J, An D, Shi L Front Genet. 2023; 13:1089405.
PMID: 36712866 PMC: 9877308. DOI: 10.3389/fgene.2022.1089405.
Delta-catenin attenuates medulloblastoma cell invasion by targeting EMT pathway.
Hu Y, Zhu S, Xu R, Wang M, Chen F, Zhang Z Front Genet. 2022; 13:867872.
PMID: 36303547 PMC: 9595215. DOI: 10.3389/fgene.2022.867872.
MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines.
Khajah M, Al-Ateyah A, Luqmani Y Biochem Biophys Rep. 2022; 31:101316.
PMID: 35879960 PMC: 9307586. DOI: 10.1016/j.bbrep.2022.101316.
-Catenin peptide vaccines repress hepatocellular carcinoma growth via CD8 T cell activation.
Huang F, Chen J, Lan R, Wang Z, Chen R, Lin J Oncoimmunology. 2018; 7(8):e1450713.
PMID: 30221043 PMC: 6136873. DOI: 10.1080/2162402X.2018.1450713.